Akums Drugs and Pharmaceuticals Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from January 1, 2026, and will continue until 48 hours after the declaration of the un-audited financial results for the quarter ending December 31, 2025. The decision to close the trading window is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct. The company will intimate the date of the Board of Directors' meeting to consider and approve these financial results in due course. This communication is for information and record purposes.